Loading provider…
Loading provider…
Pulmonary Disease Physician in Tampa, FL
NPI: 1356416531Primary Practice Location
TAMPA GENERAL HOSPITAL
1 Tampa General Cir, Tampa, FL
Primary Employer
Elitecaremds
tgh.org
HQ Phone
Get M.D. Kapilkumar's Phone Numberphone_androidMobile
Get M.D. Kapilkumar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
CA State Medical License
2008
FL State Medical License
2016 - 2026
NC State Medical License
2025 - 2026
MD State Medical License
2007 - 2013
NE State Medical License
2011 - 2011
NY State Medical License
2006 - 2008
VT State Medical License
2004 - 2008

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University of Vermont Medical Center
Fellowship • Pulmonary Disease and Critical Care Medicine
2004 - 2007
Rutgers Health/Monmouth Medical Center
Residency • Internal Medicine
2001 - 2004
Medical University of Lublin
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 135 | 272 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 102 | 130 |
| 3 | 94729Measurement of lung diffusing capacity | 80 | 81 |
| 4 | 94726Determination of lung volumes using plethysmography | 50 | 50 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 49 | 51 |
Authors: Kalpesh Ganatra
Journal: Respir Care
Addressing inherited predisposition for breast cancer in transplant recipients.
Authors: Rachel Yang, David Weill, Irene Wapnir, Allison Kurian
Publication Date: 2016-02-10
Lead Sponsor: Corbus Pharmaceuticals Inc.
Collaborators: Cystic Fibrosis Foundation
Intervention / Treatment: OTHER: Placebo, DRUG: Lenabasum 20 mg, DRUG: Lenabasum 5 mg
Lead Sponsor: Zambon SpA
Intervention / Treatment: DRUG: standard of care, DRUG: Liposomal Cyclosporine A